A Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA From 2007–2013
Crossref DOI link: https://doi.org/10.1177/2168479016646809
Published Online: 2016-12-30
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Egger, Gunter F.
Wharton, Gerold T.
Malli, Suzanne
Temeck, Jean
Murphy, M. Dianne
Tomasi, Paolo
Text and Data Mining valid from 2016-09-01
Article History
Received: 18 February 2016
Accepted: 1 April 2016
First Online: 30 December 2016